Work

†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results

Year: 2024

Type: article

Study design: Clinical Trial

Source: Journal of clinical lipidology

DOI: 10.1016/j.jacl.2024.04.098

Authors: Szilard Vasas, Masoud Azizad, Peter Clifton, Robert Rosenson, Daniel Gaudet, Jennifer Hellawell, Ting Chang, Stacey Melquist, Ran Fu, Ma'an Mushin, Javier San Martin, Christie Ballantyne

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400959548

FWCI: 0.877

Cites:

Cited by: 3

Related to: 10